CCC Intelligent Solutions Holdings Inc. financials

  1. Home
  2. Financials
  3. CCC
SEC pipeline catching up: most recent reported quarter (2026-03-31) isn't incorporated yet — this page is anchored to 2025-12-31 (FY 2025 · 10-K). New filings land within a few weekday pipeline runs.
CCC CIK 0001818201

Source: EDGAR filings · Built 2026-06-02T02:35:09Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow 254.51M 230.87M 195.00M 151.96M 89.01M 73.84M
EBITDA 152.60M 123.01M 12.98M 79.86M -120.22M 94.73M
Working Capital 100.97M 409.80M 197.09M 327.50M 186.26M 156.05M
Net Debt 1.24B 424.96M 638.01M 527.94M 681.64M 1.16B
Gross Margin 73.49% 75.55% 73.43% 72.66% 71.57% 67.03%
Operating Margin 8.88% 8.48% -2.76% 6.64% -21.02% 12.16%
Net Margin 0.16% 3.31% -10.40% 4.91% -36.16% -2.67%
Return on Equity (ROE) 0.09% 1.56% -5.05% 1.88% -13.29% -1.23%
Return on Assets (ROA) 0.05% 0.98% -2.95% 1.15% -7.69% -0.53%
Current Ratio 1.43× 3.65× 2.29× 3.16× 2.36× 2.24×
Debt-to-Equity 0.76× 0.41× 0.47× 0.42× 0.46× 0.96×
Effective Tax Rate 92.16% 29.50% -6.53% 22.98% 9.46% 21.71%
Cash Conversion Ratio 186.90× 9.09× -2.78× 5.21× -0.51× -6.16×
Accruals Ratio -0.09× -0.08× -0.11× -0.05× -0.12× -0.04×
SBC % of Revenue 16.59% 18.10% 16.68% 13.99% 38.06% 1.79%
CapEx Coverage 5.17× 5.36× 4.54× 4.17× 3.32× 3.45×
Free Cash Flow Per Share $0.39 $0.36 $0.32 $0.24 $0.16 $0.15

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
P/E Trailing (Diluted) — 293.25× — 145.00× — —
P/FCF 20.60× 32.61× 36.09× 36.80× 69.54× 90.58×
FCF Yield 4.85% 3.07% 2.77% 2.72% 1.44% 1.10%
EV / EBITDA 39.66× 63.45× 578.53× 74.38× — 82.84×
P/S 4.55× 7.81× 7.93× 6.92× 10.09× 10.57×
P/B 2.69× 3.69× 3.85× 2.65× 3.71× 4.88×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenues 1.06B 944.80M 866.38M 782.45M 688.29M 633.06M
Cost of Revenue 280.19M 231.00M 230.22M 213.94M 195.66M 208.72M
Gross Profit 776.81M 713.80M 636.16M 568.51M 492.63M 424.35M
Research and Development Expense 227.50M 201.49M 173.11M 156.96M 165.99M 109.51M
Operating Expenses 682.97M 633.70M 660.08M 516.59M 637.31M 347.37M
Operating Income (Loss) 93.84M 80.11M -23.93M 51.92M -144.68M 76.98M
Income Tax Expense (Benefit) 19.84M 13.07M 5.52M 11.46M -26.00M -4.68M
Net Income (Loss) Attributable to Parent 1.69M 31.24M -90.07M 38.41M -248.92M -16.88M
Earnings Per Share, Basic $0.00 $0.04 $-0.15 $0.06 $-0.46 $-0.03
Weighted Average Number of Shares Outstanding, Basic 629.96M 610.76M 617.89M 607.76M 543.56M 504.12M
Earnings Per Share, Diluted $0.00 $0.04 $-0.15 $0.06 $-0.46 $-0.03
Weighted Average Number of Shares Outstanding, Diluted 659.59M 641.88M 617.89M 642.84M 543.56M 504.12M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 111.19M 398.98M 195.57M 323.79M 182.54M 162.12M
Assets, Current 335.10M 564.65M 350.00M 479.07M 322.90M 281.76M
Assets 3.57B 3.18B 3.05B 3.35B 3.24B 3.20B
Long-term Debt 1.29B — 776.00M 792.00M 800.00M —
Liabilities, Current 234.13M 154.85M 152.91M 151.56M 136.65M 125.72M
Long-term Debt, Excluding Current Maturities 1.26B 761.05M 767.50M 774.13M 780.61M 1.29B
Liabilities 1.79B 1.16B 1.25B 1.29B 1.35B 1.81B
Stockholders' Equity Attributable to Parent 1.79B 2.00B 1.78B 2.05B 1.87B 1.37B
Common Stock, Shares, Outstanding 605.45M 629.21M 603.13M 622.07M 609.77M 504.27M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities 315.48M 283.89M 250.03M 199.91M 127.33M 103.94M
Payments to Acquire Property, Plant, and Equipment 60.97M 53.01M 55.03M 47.95M 38.32M 30.11M
Net Cash Provided by (Used in) Investing Activities -471.38M -53.01M -55.03M -76.29M -48.60M -30.67M
Payments for Repurchase of Common Stock 600.57M 0 328.45M 0 0 0
Payments of Dividends — — 0 0 269.17M 0
Net Cash Provided by (Used in) Financing Activities -132.11M -27.29M -323.03M 17.88M -58.44M -4.42M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CCC CIK 0001818201), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CCB

COASTAL FINANCIAL CORPORATION

KSCP

Knightscope, Inc.

SPRY

ARS Pharmaceuticals, Inc.